NASDAQ:NKBP - China Nuokang Bio-Pharmaceutical Stock Price, Price Target & More

$5.54 0.00 (0.00 %)
(As of 04/25/2018 03:02 AM ET)
Previous Close$5.54
Today's RangeN/A
52-Week RangeN/A
Average VolumeN/A
Market Capitalization$108.95 million
P/E RatioN/A
Dividend YieldN/A

About China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP)

China Nuokang Bio-Pharmaceutical Inc. is a biopharmaceutical company focused on research, development, manufacture, marketing and sales of hospital-based medical products. As of December 31, 2010, it sold a portfolio of 15 products, including four principal products: Baquting, its bleeding control product; Kaitong, its lipid emulsion alprostadil product for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis; Aiduo, its cardiovascular stress imaging agent, and Aiwen, its anti-arrhythmic agent. Its product pipeline includes three product candidates under development for bleeding control and hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. In February 2013, it announced the completion of the merger with Kingbird Mergerco. Inc., a wholly owned subsidiary of Kingbird Investment Inc. As a result of the merger the Company became a wholly owned subsidiary of Kingbird Investment Inc.

Receive NKBP News and Ratings via Email

Sign-up to receive the latest news and ratings for NKBP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

How to Become a New Pot Stock Millionaire

China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP) Frequently Asked Questions

What is China Nuokang Bio-Pharmaceutical's stock symbol?

China Nuokang Bio-Pharmaceutical trades on the NASDAQ under the ticker symbol "NKBP."

Has China Nuokang Bio-Pharmaceutical been receiving favorable news coverage?

News articles about NKBP stock have trended positive this week, Accern reports. The research group identifies positive and negative news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. China Nuokang Bio-Pharmaceutical earned a daily sentiment score of 0.35 on Accern's scale. They also gave press coverage about the biopharmaceutical company an impact score of 48.19 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

How do I buy shares of China Nuokang Bio-Pharmaceutical?

Shares of NKBP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is China Nuokang Bio-Pharmaceutical's stock price today?

One share of NKBP stock can currently be purchased for approximately $5.54.

How big of a company is China Nuokang Bio-Pharmaceutical?

China Nuokang Bio-Pharmaceutical has a market capitalization of $108.95 million.

How can I contact China Nuokang Bio-Pharmaceutical?

China Nuokang Bio-Pharmaceutical's mailing address is No. 18-1 East Nanping Road Hunnan Natnl New & High-tch Dvlpmnt Zone, SHENYANG, LIA 110171, China. The biopharmaceutical company can be reached via phone at +86-24-24696033.

MarketBeat Community Rating for China Nuokang Bio-Pharmaceutical (NKBP)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  43 (Vote Outperform)
Underperform Votes:  31 (Vote Underperform)
Total Votes:  74
MarketBeat's community ratings are surveys of what our community members think about China Nuokang Bio-Pharmaceutical and other stocks. Vote "Outperform" if you believe NKBP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NKBP will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/25/2016 forward)


China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP) Earnings History and Estimates Chart

Earnings by Quarter for China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP)

China Nuokang Bio-Pharmaceutical (NASDAQ NKBP) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/25/2012Q3 2012$0.06$0.10ViewN/AView Earnings Details
8/22/2012Q2 2012$0.07$0.09ViewN/AView Earnings Details
5/23/2012Q1 2012$0.01ViewN/AView Earnings Details
3/14/2012Q4 2011($0.07)($0.09)ViewN/AView Earnings Details
11/17/2011Q3 2011$0.07$0.06ViewN/AView Earnings Details
8/25/2011$0.11$0.11ViewN/AView Earnings Details
5/25/2011Q1 2011$0.05$0.08ViewN/AView Earnings Details
3/16/2011$0.06$0.01ViewN/AView Earnings Details
11/17/2010Q3 2010$0.11$0.07ViewN/AView Earnings Details
8/25/2010Q2 2010$0.16$0.14ViewN/AView Earnings Details
6/2/2010Q1 2010$0.07$0.13ViewN/AView Earnings Details
3/16/2010Q4 2009$0.16$0.21ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

China Nuokang Bio-Pharmaceutical (NASDAQ NKBP) Insider Trading and Institutional Ownership History

Insider Trading History for China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP)

China Nuokang Bio-Pharmaceutical (NASDAQ NKBP) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)


China Nuokang Bio-Pharmaceutical (NASDAQ NKBP) News Headlines

No headlines for this company have been tracked by

SEC Filings

China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


China Nuokang Bio-Pharmaceutical (NASDAQ:NKBP) Income Statement, Balance Sheet and Cash Flow Statement


China Nuokang Bio-Pharmaceutical (NASDAQ NKBP) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.